Mölnlycke Health Care is a world leading provider of single-use surgical and wound care products and services for the professional health care sector.

The Surgical Division manufactures advanced drapes, sets and staff clothing, surgical powder free gloves, skin antiseptics and custom procedure trays.

The Wound Care Division produces unique wound healing products based on a patented adhesive technology, Safetac®, absorbent and fixation dressings, products for compression, dermatology and orthopedics as well as bioactive treatment for hard-to-heal wounds. We are particularly well known for our unique range of products and patented technologies.

Key brands include BARRIER®, Biogel®, HiBi® and ProcedurePak®, Mepilex®, Mepitel®, Mepore®, Mefix®, Tubifast®, Tubigrip® and Xelma®.

Mölnlycke Health Care has 6,200 employees and 24 offices around the world. Headquarters are in Gothenburg, Sweden. The company’s manufacturing plants are located in Belgium, the Czech Republic, Finland, Malaysia, Thailand, France and the UK. Mölnlycke Health Care is owned by Investor and Morgan Stanley.